ISRCTN40815027进行中（未招募）未知
Verification of urinary Xpert bladder cancer detection test in patients with haematuria
niversity of Dundee0 个研究点目标入组 600 人开始时间: 2020年12月23日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Adults over the age of 18
- •2. Presenting with visible and non-visible haematuria within 12 weeks of the consent visit
- •3. Scheduled for a standard of care cystoscopy
- •4. Agrees to provide voided urine for trial purposes
- •5. Able to consent
排除标准
- •1. Previous diagnosis of bladder cancer
- •2. Previous history of kidney stone
- •3. Indwelling urethral catheter
- •4. Ongoing urinary tract infection
- •5. Not able to consent
研究者
相似试验
进行中（未招募）
不适用
Detection of bladder cancer using a fluorescent dye (PVP-Hypericin)Suspected non-muscle invasive (superficial) bladder cancerMedDRA version: 17.0Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-001819-30-DESanochemia Pharmazeutika AG220
进行中（未招募）
不适用
Detection of bladder cancer using a fluorescent dye (PVP-Hypericin)Suspected non-muscle invasive (superficial) bladder cancerMedDRA version: 17.0Level: PTClassification code 10005003Term: Bladder cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-001819-30-ATSanochemia Pharmazeutika AG220
已完成
2 期
Detection of non-muscle invasive bladder cancer using PVP-Hypericin (Vidon®) fluorescence cystoscopy(Hypericin PDD)C67Malignant neoplasm of bladderDRKS00003324Sanochemia Pharmazeutika AG227
尚未招募
不适用
Diagnosis of bladder cancer using probe-based confocal laser endomicroscopyBladder CancerJPRN-UMIN000021067Depatment of Urology, Kyoto Prefectural University of Medicine50
已完成
不适用
Xpert bladder cancer monitor test for bladder cancer surveillanceon-muscle invasive bladder cancerNon-muscle invasive bladder cancerCancerISRCTN37210907Medical University Innsbruck150